KYRNF Financials
KYORIN Pharmaceutical Co., Ltd. - Financial statements & key metrics
Stock Price
$10.31
Market Cap
$592.33M
P/E Ratio
10.1
EPS
$1.02
Income Statement Highlights
Most Recent Quarter: 2025-03-31
Revenue
$130.09B
Gross Profit
$59.53B
Operating Income
$12.57B
Net Income
$9.09B
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$193.62B
Total Liabilities
$57.33B
Shareholders Equity
$136.28B
Cash & Equivalents
$15.02B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$3.51B
CapEx
$6.29B
Free Cash Flow
$-2.79B
Profitability Metrics
Gross Margin
45.3%
Operating Margin
0.1%
Net Margin
0.1%
ROE
0.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is KYRNF revenue?
KYRNF's most recent quarterly revenue was $130.09B. Annual revenue can be calculated by summing the four most recent quarters.
Is KYRNF profitable?
KYRNF reported a profit of $9.09B in the most recent quarter. The net profit margin is 0.1%.
What is KYRNF market cap?
KYRNF has a market capitalization of $592.33M, making it a small-cap stock.
Does KYRNF have debt?
View KYRNF's balance sheet for debt information.
What is KYRNF cash flow?
KYRNF's most recent quarterly free cash flow was $-2.79B.